Skip to content

Nevirapine rather than efavirenz-based HIV treatment more likely to suppress viral load to zero

England: national commissioning of HIV testing and treatment, local government to fund sexual health clinics

New joint guidelines on IPT and intensified case-finding from WHO

Bristol-Myers Squibb buys festinavir, new NRTI active against MDR HIV

Prompt treatment and better screening could prevent many cancer deaths in patients taking HIV therapy

Lopinavir/ritonavir monotherapy a possible second-line option for treatment experienced children

Male partner involvement in PMTCT reduces HIV transmission risk

European recommendations issued on acute hepatitis C infection in patients with HIV

Once-daily darunavir approved for some treatment-experienced patients in US